Behind every patient stands a multidisciplinary team of cancer specialists who work together to determine the best care plan for each patient, and across our campus leading scientists and researchers work daily to unlock the clues to cancer.
Hollings Cancer researchers publish results, in The Lancet Oncology about a novel immunotherapy combination that shows promise for lung cancer patients.
The 3rd Annual Linda Floyd Forum on Women's Cancers is complimentary event to share, learn and engage in dialogue with experts from the Hollings Cancer Center.
This year, more breakthroughs will be discovered. More cancer patients will find hope. And Hollings Cancer Center will be on the leading edge of offering better options to patients. As a cancer center that combines patient care and research, Hollings brings together over 180 physicians and scientists who are driving the discoveries that will lead to tomorrow’s treatments.
Quality & Awards
The only National Cancer Institute-Designated Cancer Center in South Carolina, Hollings is at the forefront of cancer research. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public, and to establish outreach services for underserved populations.
- Senator Ernest "Fritz" Hollings
Health Focus: SC Public RadioBobbi Conner talks with Dr. Sharlene Wedin about coping with chronic illness.
Hollings in the CommunityApril 27, 2018
12:00 p.m. to 1:00 p.m. | HCC 120
Kai Wucherpfennig, M.D., Ph.D.
Professor of Microbiology & Immunobiology,
Harvard Medical School Chair & Professor; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute
"Resistance to Cancer Immunotherapy”
As one of the leading cancer treatment centers in the Southeast, Hollings Cancer Center combines the full range of cancer specialties to deliver a higher level of care to the patients we serve. Our team of more than 60 sub-specialists – each concentrating on a specific discipline of cancer treatment and care – works with individual patients to develop customized treatment programs that target a broad range of conditions. Our specialists work together as a team, often meeting with patients under the same roof on the same day. We are striving to deliver the highest level of care in the best way possible.
The heart of our patient care is located in downtown Charleston, SC. Patients may also be seen in oncology clinic locations closer to home.
Personalized patient care is at the center of everything we do. And no one tells the story better than our patients themselves. Meet some of our patients and hear about their cancer journey.
Patient Stories
Patients may be referred to Hollings by calling MEDULINE at 843-792-2200 or 800-922-5250, MUSC’s dedicated consultation line open 24/7 exclusively for health care professionals or through the online Patient Referral Portal.
Find a Nurse Navigator
Hollings offers resources for patients, families and those interested in learning more about cancer prevention and risk. These include our Patient & Family Resource Room, the online MUSC Health Library and many services and support networks.
Patient Resources
Every treatment that has ever made a difference in cancer was once a part of a clinical trial. The Hollings Cancer Center is committed to offering the best treatments available today while searching for even better ones for the future.
As an NCI-Designated Cancer Center, Hollings Cancer Center is part of a national network of clinical trials, with access to hundreds of trials across the United States.
Hollings Cancer Center is home to more than 120 scientists conducting research and collaborating on better ways to prevent, detect, diagnose and treat this complex disease. As one of 69 National Cancer Institute-Designated Cancer Centers, Hollings continues to attract top cancer researchers from leading institutions across the country who are conducting research in the community, laboratory and clinic.
The HCC Fellowship Program is currently accepting applications for Postdoctoral/Clinical Fellows and Graduate Fellows. The program is designed to train the next generation of exceptional cancer scientists in the fields of basic, translational, population or clinical sciences.